Rocco Spagnuolo

32PUBLICATIONS
139CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Rheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Metabolic medicineFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 10, 2026
Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease-A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).

|Feb 18, 2026
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.

Franco Scaldaferri, Federica Di Vincenzo, Marina Aloi

|Nov 13, 2025
Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study.

Giammarco Mocci, Antonio Tursi, Franco Scaldaferri

|Oct 28, 2025
Gut Microbiota Changes in Metabolic Dysfunction-Associated Steatohepatitis and Inflammatory Bowel Disease: Common Pathogenic Features.

Giuseppe Guido Maria Scarlata, Domenico Morano, Abdulrahman Ismaiel

|Jul 12, 2025
Interleukin 23: Pathogenetic Involvement and Therapeutic Target for Ulcerative Colitis.

Laura Parisio, Giuseppe Cuccia, Anna Giudice

|Jun 26, 2025
Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies.

Vincenzo Trapanese, Annamaria Dagostino, Maria Resilde Natale

Pageof 6

Frequent Collaborators

11 joint publications

Francesco Luzza

8 joint publications

Ludovico Abenavoli

6 joint publications

Giuseppe Guido Maria Scarlata

5 joint publications

Luigi Boccuto